Moneycontrol
HomeNewsBusinessAnnouncementsGlenmark Pharma receives ANDA approval for Rosuvastatin calcium tablets
Trending Topics

Glenmark Pharma receives ANDA approval for Rosuvastatin calcium tablets

Glenmark Pharmaceuticals Inc USA has been granted final approval by the USFDA for Rosuvastatin Calcium Tablets, 5 mg (base), 10 mg (base), 20 mg (base), and 40 mg (base), the generic version of Crestor tablets, 5 mg, 10 mg, 20 mg, and 40 mg of IPR Pharmaceuticals Inc.

July 20, 2016 / 08:55 IST
Story continues below Advertisement

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 20, 2016, titled "Glenmark Pharmaceuticals receives ANDA approval for Rosuvastatin Calcium Tablets, 5 mg (base), 10 mg (base), 20 mg (base), and 40 mg (base)".Source : BSE

Read all announcements in Glenmark

first published: Jul 20, 2016 08:55 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!